openPR Logo
Press release

Graves Disease Market: Industry Analysis, Pipeline, Drugs, Companies by DelveInsight | Novartis, Abbott Laboratories, GlaxoSmithKline, Merck, Pfizer and Many Others

07-21-2022 06:52 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Graves Disease Market

Graves Disease Market

DelveInsight's "Graves' Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graves' Disease, historical and forecasted epidemiology as well as the Graves' Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know more about Graves' Disease Market Report: https://www.delveinsight.com/report-store/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some facts of Graves' Disease Market Report:
• According to National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), the disease affects about 1 in 200 people in the United States and is the most common cause of hyperthyroidism.
• According to an article by Wemeau et al. (2018), of 1,572 hyperthyroid patients living in France, 73.3% had Graves' disease (either primary or recurrence), of whom 85% were female, with a mean age of 43 years (primary onset) to 44 years (recurrence).
• The National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), estimates that 30 percent of people who develop Graves' disease will get a mild case of Graves' ophthalmopathy. Up to 5 percent will get severe Graves' ophthalmopathy.
• As per American Thyroid Association (n.d.), the Graves' Disease is 7-8 times more common in women than men.
• According to Cleveland Clinic (n.d.), Graves' disease affects one out of every 200 Americans, making it the top cause of hyperthyroidism.

To Know more about Graves' Disease Market Report: https://www.delveinsight.com/report-store/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Graves' Disease Companies are:
• Novartis
• Abbott Laboratories
• GlaxoSmithKline
• Merck & Co., Inc
• Pfizer, Inc.
• RLC LABS
• AbbVie, Inc.
• Mylan N.V.
• Allergan, plc
• And Many Others

To Know more about Graves' Disease Market Report: https://www.delveinsight.com/report-store/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Graves' Disease is a common form of hyperthyroidism. In this autoimmune disease, the immune system creates antibodies known as thyroid-stimulating immunoglobulins. They then attach to healthy thyroid cells thus, causing one's thyroid to create too much thyroid hormone.
Thyroid hormones affects various aspects of nervous system function, brain development, body temperature and other important elements. If left untreated, it causes weight loss, anxiety, jitteriness, irritability, depression, and mental or physical fatigue. Apart from these, other complications include eye problems, heart problems, skin problems etc.
Hand tremors, weight loss, rapid heart rate, intolerance to heat, fatigue, nervousness, irritability, muscle weakness, goiter, difficult sleeping and frequent formed bowel movements are some of the symptoms shared by individuals affected with Graves' disease and hyperthyroidism.

Some of Graves' Disease Therapies are:
• Iscalimab
• Secukinumab
• And Many Others

To Know more about Graves' Disease Market Report: https://www.delveinsight.com/report-store/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of Graves' Disease Report:
• The report covers the descriptive overview of Graves' Disease, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Graves' Disease epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Graves' Disease are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Graves' Disease market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Graves' Disease market

Request for free sample report: https://www.delveinsight.com/sample-request/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Graves' Disease
3. Competitive Intelligence Analysis for Graves' Disease
4. Graves' Disease: Market Overview at a Glance
5. Graves' Disease: Disease Background and Overview
6. Patient Journey
7. Graves' Disease Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Graves' Disease Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Graves' Disease: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Graves' Disease
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Request for free sample report: https://www.delveinsight.com/sample-request/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/
Request for free sample report: https://www.delveinsight.com/report-store/graves-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Graves Disease Market: Industry Analysis, Pipeline, Drugs, Companies by DelveInsight | Novartis, Abbott Laboratories, GlaxoSmithKline, Merck, Pfizer and Many Others here

News-ID: 2686290 • Views:

More Releases from DelveInsight Business Research

Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining the Future of Treatment, analyses DelveInsight
Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining …
DelveInsight's newly released report, "Geographic Atrophy Pipeline Insight" offers a comprehensive analysis of the evolving Geographic Atrophy (GA) therapeutic landscape, covering 23+ biopharmaceutical companies and 25 investigational drug candidates. The report features in-depth profiles of both clinical- and preclinical-stage assets, along with a detailed therapeutic assessment categorized by product type, development phase, route of administration, and molecular class. It also provides visibility into inactive and discontinued pipeline programs within the
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies Advancing Next-Generation ILD Therapies, analyses DelveInsight
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies …
DelveInsight, a prominent market intelligence and consulting organization in the life sciences domain, has announced the launch of its newest report titled "Interstitial Lung Disease Pipeline Insight, 2025." The publication delivers a comprehensive analysis of the fast-advancing therapeutic environment for Interstitial Lung Disease (ILD). With over 120 biopharmaceutical companies actively developing 120+ pipeline assets, the ILD pipeline is witnessing remarkable growth fueled by strong scientific innovation, clinical progress, and regulatory
Global Vein Illumination Devices Market Forecast to Reach USD 152.83 Million by 2032, estimates DelveInsight
Global Vein Illumination Devices Market Forecast to Reach USD 152.83 Million by …
DelveInsight's latest publication, "Vein Illumination Devices Market Insights, Competitive Landscape and Market Forecast-2032," offers a comprehensive analysis of existing and future market dynamics. The report examines evolving trends, technological advancements, key market challenges, growth catalysts, and limiting factors, while also showcasing upcoming product launches and profiling the major players influencing the vein illumination devices industry. Based on DelveInsight's most recent evaluation, the global vein illumination devices market is anticipated to experience
Liver Cancer Clinical Trial Analysis: 75+ Drugs, 70+ Companies Redefining the Future of Treatment, analyses DelveInsight
Liver Cancer Clinical Trial Analysis: 75+ Drugs, 70+ Companies Redefining the Fu …
DelveInsight's "Liver Cancer Pipeline Insights 2025" delivers an in-depth overview of the liver cancer pipeline ecosystem, profiling more than 70 companies and 75+ therapeutic candidates under development. The report thoroughly examines liver cancer drug profiles across both clinical and preclinical stages. It also evaluates the therapeutic landscape by product category, development phase, route of administration, and molecular class, while additionally identifying inactive and discontinued assets within the pipeline. Stay informed with

All 5 Releases


More Releases for Graves

Graves' Disease Market New Product Development & Latest Trends
Introduction Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the most common thyroid-related autoimmune conditions, disproportionately affecting women between 30-60 years of age. Beyond metabolic complications such as weight loss, heat intolerance, and palpitations, Graves' disease can cause thyroid eye disease (TED), which impairs vision and quality of life. For decades, treatment has relied on antithyroid
Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graves Ophthalmopathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Graves Ophthalmopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Graves Ophthalmopathy Research. Learn more about
Search for graves and burials in Minsk
If you are looking for information about the location of the grave in Minsk or other regions of Belarus, the company https://verimby.com +375293887408 (Viber); +375447498518 (WhatsApp) offers professional assistance in this important matter. We specialize in finding burial sites, providing detailed data and providing support in restoring lost ties with the past, creating a family tree, even if you are in another country. Why can the search for graves in Belarus
Graves' Disease Treatment Market Size, Drugs, Companies 2034 | DelveInsight
Graves' Disease Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Graves' Disease Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence. DelveInsight's "Graves' Disease Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Graves' Disease, historical and
Japan Graves' disease Market Size & Growth Analysis Report, 2019-2025
Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in
Global Graves Disease Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Graves Disease Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Graves Disease Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/515950/graves-disease Market